PATIENT-REPORTED WELL-BEING USING TILDRAKIZUMAB IN A REAL-WORLD SETTING: 52WEEK INTERIM DATA OF THE PHASE IV POSITIVE STUDY
Loading...
Date
Journal Title
Journal ISSN
Volume Title
dc.identifier.issn
0001-5555
1651-2057
1651-2057
dc.identifier.doi
dc.identifier.other
dc.description.volume
104
dc.description.issue
Publisher
ACTA DERMATO-VENEREOLOGICA